Peptides and Combination of Peptides of Non-Canonical Origin for Use in Immunotherapy Against Different Types of Cancers
Copyright © Targeted News Service 2024
2024-04-09
ALEXANDRIA, Virginia, April 9 -- IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen, Germany has been assigned a patent (No. US 11951132 B2, initially filed July 16, 2021) developed by seven inventors Heiko Schuster, Tuebingen, Germany; Franziska Hoffgaard, Tuebingen, Germany; Jens Fritsche, Dusslingen, Germany; Oliver Schoor, Tuebingen, Germany; Toni Weinschenk, Aichwald, Germany; Daniel Johannes Kowalewski, Kirchentellinsfurt, Germany; and Chih-Chiang Tsou, Pearland, Texas, for "Peptides and combinatio . . .